Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

NCT01109069

Conditions
B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
Locations
  • Stanford University Stanford, California, United States
  • Stanford, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata

NCT02974868

Conditions
Alopecia, Alopecia Areata, Hair Diseases, +13 more
Locations
  • University of Alabama at Birmingham, Dermatology at the Whitaker Clinic Birmingham, Alabama, United States
  • University of Alabama at Birmingham, The Kirklin Clinic Birmingham, Alabama, United States
  • Southern California Dermatology, Inc. Santa Ana, California, United States
  • Clinical Science Institute Santa Monica, California, United States
View all 55 locations
View Trial Details
Completed

Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)

NCT01196520

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
Locations
  • Bugando Medical Center Mwanza, Tanzania
  • Shirati Health, Educational, and Development Foundation Shirati, Tanzania
  • St.Mary's Hospital Lacor Gulu, Uganda
  • Kuluva Hospital (Arua) Kampala, Uganda
View Trial Details
Completed

A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer

NCT03027284

Conditions
Adenocarcinoma, Advanced Cancer, Biliary Tract Carcinoma, +27 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan
View Trial Details
Completed

MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma

NCT02764281

Conditions
Extranodal NK-T-Cell Lymphoma, Nasal Type, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations
  • Shanghai Ninth People's Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Eye Ear Nose and Throat Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
  • Xinhua Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Completed

A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma

NCT02460276

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Rigshospitalet Copenhagen, Denmark
  • Helsinki University Hospital Helsinki, Finland
  • Norwegian Radium Hospital Oslo, Norway
  • Lund University Hospital Lund, Sweden
View Trial Details

Related conditions